The Malaysian business of India's largest biotech firm Biocon has received a Good Manufacturing Practice (GMP) compliance certificate from the European Medicine 22 August 2019
Draft guidance has been published on the US Food and Drug Administration’s (FDA) recommendations for the design and evaluation of comparative analytical studies 22 May 2019
The Canadian unit of Israeli generics firm Teva Pharmaceutical has been granted approval for its biosimilar product Truxima (rituximab), referencing Rituxan. 15 April 2019
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.